Medicine Description olmespironova 20/12.5mg
olmespironova 20/12.5mg tablets is a medication that combines two active ingredients: olmesartan, an angiotensin II receptor blocker (ARB), and hydrochlorothiazide, a thiazide diuretic. The olmesartan component works by inhibiting the action of angiotensin II, a hormone that causes blood vessels to constrict. By blocking its action, olmesartan promotes vasodilation, which effectively lowers blood pressure. Meanwhile, hydrochlorothiazide acts on the kidneys to prevent the reabsorption of sodium, leading to increased excretion of sodium and water. This diuretic effect reduces blood volume, which contributes further to lowering blood pressure. When used in combination, these two mechanisms work synergistically to provide a more effective treatment for hypertension and improve cardiovascular outcomes.
Indications and Uses of olmespironova 20/12.5mg tablets
- Management of essential hypertension
- Treatment of hypertension in patients with heart failure
- Reduction of the risk of cardiovascular events
Side Effects of olmespironova 20/12.5mg tablets
- Dizziness
- Fatigue
- Hypokalemia (low potassium levels)
- Hypotension (low blood pressure)
- Increased urination
- Allergic reactions (rare)
Storage and Handling
Store olmespironova 20/12.5mg tablets at room temperature, away from moisture and heat. Keep the tablets in their original container and out of reach of children.
Patient Advice and Precautions
Patients should be advised to maintain regular monitoring of blood pressure during treatment. It is important to inform healthcare providers about any pre-existing conditions, especially kidney issues or electrolyte imbalances, as these may affect treatment. Additionally, patients should be counseled to recognize signs of hypotension, such as dizziness or fainting, and to avoid sudden changes in posture.